小剂量尿激酶与低分子肝素钙联合治疗进展性脑血栓的效果观察  

Effect Observation of Small Dose Urokinase Combined With Low Molecular Weight Heparin Calcium in the Treatment of Progressive Cerebral Thrombosis

作　　者：刘晓晗 

机构地区：[1]山东省枣庄市立第四医院,277500

出　　处：《中国卫生标准管理》2015年第16期105-106,共2页China Health Standard Management

摘　　要：目的讨论并分析在进展性脑血栓治疗中小剂量尿激酶与低分子肝素钙联合治疗的临床效果。方法选取我院2011年8月∽2013年11月收治的50例进展性脑血栓患者为研究对象,采用随机分组的方式将患者平均分为观察组和对照组,对照组患者行常规治疗,观察组患者小剂量尿激酶联合低分子肝素钙治疗,综合对比两组患者的治疗效果。结果经过系统的治疗,两组患者在不良反应发生率和神经功能缺损改善情况比较,观察组均优于对照组（P〈0.05）。结论在进展性脑血栓患者的治疗中,采用小剂量尿激酶联合低分子肝素钙的治疗方法,具有一定的临床价值。Objective To discuss and analyze the clinical effect of small dose urokinase combined with low molecular weight heparin in the treatment of progressive cerebral thrombosis. Methods 50 patients with progressive cerebral thrombosis from August 2011 to November 2013 in our hospital were selected into observation group and control group randomly. The patients in control group received routine treatment,the observation group patients received low dose urokinase combined with low molecular heparin calcium treatment,and the treatment effects of two groups were copared. Results The incidence of adverse reactions and neurologic impairment improvement in the observation group were better than control group significantly（P〈0.05）. Conclusion The clinical effect of small dose urokinase combined with low molecular weight heparin in the treatment of progressive cerebral thrombosis is better,and the method has certain clinical value.

关 键 词：进展性脑血栓 小剂量尿激酶 低分子肝素 临床效果 

分 类 号：R743.3[医药卫生—神经病学与精神病学]